340B providers and advocates vocally pressed two high-ranking CMS officials Tuesday for answers on the Trump administration’s reasons for pursuing [...] …
Articles by : Shannon Young, Managing Editor
A new potential 340B rebate pilot, drugmaker 340B in-house pharmacy claims data requirements and new congressional reform proposals dominated discussions [...] …
Please Login or Become a Paid Subscriber to View this Content
Switzerland-based Novartis this week began requiring all 340B covered entities to submit pharmacy and medical claims data on all dispenses, [...] …
Please Login or Become a Paid Subscriber to View this Content
AHA recently announced that it has selected the head of a Massachusetts hospital trade group to take over as its [...] …
Please Login or Become a Paid Subscriber to View this Content
AbbVie recently announced 340B contract pharmacy restrictions for its new federally approved drug used to treat Blastic plasmacytoid dendritic cell [...] …
Please Login or Become a Paid Subscriber to View this Content
The U.S. House Ways and Means Committee approved legislation along party lines Wednesday that would require certain nonprofit hospitals to [...] …
Please Login or Become a Paid Subscriber to View this Content
A Colorado congresswoman, who has played a key role in shaping health and 340B policy on Capitol Hill for nearly [...] …
Please Login or Become a Paid Subscriber to View this Content
340B stakeholders recently offered mixed reactions to a key—but outgoing—Republican U.S. senator’s sweeping proposal that would allow drug manufacturer 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
A New Jersey-based drugmaker recently announced that its 340B contract pharmacy restrictions and in-house pharmacy claims data requirements no longer [...] …
Please Login or Become a Paid Subscriber to View this Content
A key U.S. House subcommittee with jurisdiction over the 340B program will hear testimony today from Medicaid directors in four [...] …